2:04
- wellness
- October 12, 2023
Ozempic shows promising signs of treating kidney failure, company says
The drug’s maker, Novo Nordisk, halted a study that showed promising preliminary results in treating kidney failure in patients with diabetes.
The drug’s maker, Novo Nordisk, halted a study that showed promising preliminary results in treating kidney failure in patients with diabetes.